Restructuring - Narrative (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 28, 2025 |
Dec. 29, 2024 |
Dec. 31, 2023 |
|
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring charges | $ 228 | $ 234 | $ 489 |
| R&D Restructuring Plan | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring charges | 100 | 500 | |
| Restructuring and Related Cost, Cost Incurred to Date | 600 | ||
| Orthopaedics Restructuring Plan | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring charges | 300 | $ 200 | $ 300 |
| Restructuring and Related Cost, Cost Incurred to Date | 800 | ||
| Surgery Restructuring Plan | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Restructuring charges | 200 | ||
| Surgery Restructuring Plan | Minimum | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Pre-tax restructuring charges | 900 | ||
| Surgery Restructuring Plan | Maximum | |||
| Restructuring Cost and Reserve [Line Items] | |||
| Pre-tax restructuring charges | $ 1,000 | ||
| X | ||||||||||
- Definition Amount of costs incurred to date for the specified restructuring cost. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount expected to be recognized in earnings for the specified restructuring cost. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|